Semi-Annual Statement Of Cash Flows

BrightPath Biotherapeutics Co., Ltd. - Filing #7719076

Concept 2018-04-01 to
2018-09-30
As at
2018-09-30
As at
2018-03-31
2017-04-01 to
2017-09-30
As at
2017-09-30
As at
2017-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-1,015,067,000 JPY
-685,187,000 JPY
Depreciation
46,904,000 JPY
24,724,000 JPY
Impairment losses
192,671,000 JPY
JPY
Interest and dividend income
-31,000 JPY
-23,000 JPY
Decrease (increase) in trade receivables
65,861,000 JPY
13,417,000 JPY
Decrease (increase) in inventories
25,169,000 JPY
15,055,000 JPY
Increase (decrease) in trade payables
19,998,000 JPY
-2,239,000 JPY
Other, net
-110,076,000 JPY
-16,849,000 JPY
Subtotal
-765,869,000 JPY
-638,472,000 JPY
Interest and dividends received
31,000 JPY
23,000 JPY
Income taxes paid
-1,925,000 JPY
-3,255,000 JPY
Net cash provided by (used in) operating activities
-760,621,000 JPY
-641,404,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-139,496,000 JPY
-30,745,000 JPY
Net cash provided by (used in) investing activities
-140,393,000 JPY
-32,120,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
-4,700,000 JPY
10,680,000 JPY
Net increase (decrease) in cash and cash equivalents
-905,714,000 JPY
-662,844,000 JPY
Cash and cash equivalents
5,623,045,000 JPY
6,528,759,000 JPY
4,287,725,000 JPY
4,950,570,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.